Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Tech Transfer Awards
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • NIH IRP Access Planning Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCI

RECOMBINANT PSEUDOMONAS EXOTOXIN WITH INCREASED ACTIVITY

  • Read more about RECOMBINANT PSEUDOMONAS EXOTOXIN WITH INCREASED ACTIVITY
Patent Cooperation Treaty
PCT/US1993/005858
Filed on 1993-06-17

PHOSPHONOALKYL PHENLYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS

  • Read more about PHOSPHONOALKYL PHENLYLALANINE COMPOUNDS SUITABLY PROTECTED FOR USE IN PEPTIDE SYNTHESIS
Patent Cooperation Treaty
PCT/US1993/005466
Filed on 1993-06-11

METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT

  • Read more about METHODS AND COMPOSITIONS FOR INCREASING THE SENSITIVITY OF A CELL TO A DNA DAMAGING AGENT
Patent Cooperation Treaty
PCT/US1993/004826
Filed on 1993-05-20

TARGETING GENE EXPRESSION TO LIVING TISSUE USING JET INJECTION

  • Read more about TARGETING GENE EXPRESSION TO LIVING TISSUE USING JET INJECTION
Patent Cooperation Treaty
PCT/US1993/004831
Filed on 1993-05-21

DEVELOPMENT OF A VECTOR TO TARGET GENE EXPRESSION TO THE EPIDERMIS OF TRANSGENIC ANIMALS

  • Read more about DEVELOPMENT OF A VECTOR TO TARGET GENE EXPRESSION TO THE EPIDERMIS OF TRANSGENIC ANIMALS
Patent Cooperation Treaty
PCT/US1993/003985
Filed on 1993-04-28

IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES

  • Read more about IMMORTALIZED HUMAN CELL LINES CONTAINING EXOGENOUS CYTOCHROME P450 GENES
Patent Cooperation Treaty
PCT/US1993/003336
Filed on 1993-04-09

USE OF NITRIC OXIDE/NUCLEOPHILE COMPLEXES FOR THE TREATMENT OF CANCER

  • Read more about USE OF NITRIC OXIDE/NUCLEOPHILE COMPLEXES FOR THE TREATMENT OF CANCER
Patent Cooperation Treaty
PCT/US1993/002922
Filed on 1993-03-29

CALANOLIDE ANTIVIRAL COMPOUNDS, COMPOSITIONS AND USES THEREOF

  • Read more about CALANOLIDE ANTIVIRAL COMPOUNDS, COMPOSITIONS AND USES THEREOF
Patent Cooperation Treaty
PCT/US1993/002810
Filed on 1993-03-24

POTENT PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR THE HIV-1 ENVELOPE

  • Read more about POTENT PEPTIDE FOR STIMULATION OF CYTOTOXIC T LYMPHOCYTES SPECIFIC FOR THE HIV-1 ENVELOPE
Patent Cooperation Treaty
PCT/US1993/001925
Filed on 1993-03-08

HEPATIC GROWTH FACTOR RECEPTOR

  • Read more about HEPATIC GROWTH FACTOR RECEPTOR
Patent Cooperation Treaty
PCT/US1993/000824
Filed on 1993-02-05

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 1497
  • Page 1498
  • Page 1499
  • Page 1500
  • Page 1501
  • Page 1502
  • Page 1503
  • Page 1504
  • Page 1505
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCI
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health